Literature DB >> 31464712

Incidence and risk factors of postoperative delirium in patients admitted to the ICU after elective intracranial surgery: A prospective cohort study.

Chun-Mei Wang1, Hua-Wei Huang, Yu-Mei Wang, Xuan He, Xiu-Mei Sun, Yi-Min Zhou, Guo-Bin Zhang, Hong-Qiu Gu, Jian-Xin Zhou.   

Abstract

BACKGROUND: Postoperative delirium (POD) has been confirmed as an important complication after major surgery. However, neurosurgical patients have usually been excluded in previous studies. To date, data on POD and risk factors in patients after intracranial surgery are scarce.
OBJECTIVES: To determine the incidence and risk factors of POD in patients after intracranial surgery.
DESIGN: Prospective cohort study.
SETTING: A neurosurgical ICU of a university-affiliated hospital, Beijing, China.
INTERVENTIONS: Adult patients admitted to the ICU after elective intracranial surgery under general anaesthesia were consecutively enrolled between 1 March 2017 and 2 February 2018. Delirium was assessed using the Confusion Assessment Method for the ICU. POD was diagnosed as Confusion Assessment Method for the ICU positive on either postoperative day 1 or day 3. Patients were classified into groups with or without POD. Data were collected for univariate and multivariate analyses to determine the risk factors for POD.
RESULTS: A total of 800 patients were included. POD was diagnosed in 157 patients (19.6%, 95% confidence interval 16.9 to 22.4%). Independent risk factors for POD included age, nature of intracranial lesion, frontal approach craniotomy, duration of surgery, presence of an episode of low pulse oxygenation at ICU admission, presence of inadequate emergence and emergence delirium, postoperative pain and presence of immobilising events. POD was associated with adverse outcomes and high costs.
CONCLUSION: POD is prevalent in patients after elective intracranial surgery. The identified risk factors for and the potential association of POD with adverse outcomes suggest that a comprehensive strategy involving screening for predisposing factors and early prevention of modifiable factors should be established in this population. TRIAL REGISTRATION: ClinicalTrials.gov NCT03087838.

Entities:  

Year:  2020        PMID: 31464712     DOI: 10.1097/EJA.0000000000001074

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  7 in total

1.  Dexmedetomidine for the prevention of postoperative delirium in patients after intracranial operation for brain tumours (DEPOD study): a study protocol and statistical plan for a multicentre randomised controlled trial.

Authors:  Xuan He; Kun-Ming Cheng; Linlin Zhang; Hongqiu Gu; Xin Qu; Yuan Xu; Penglin Ma; Jian-Xin Zhou
Journal:  BMJ Open       Date:  2020-11-23       Impact factor: 2.692

2.  Outcome, demography and resource utilization in ICU Patients with delirium and malignancy.

Authors:  Mattia Sieber; Alain Rudiger; Maria Schubert; Dominique Bettex; Reto Schüpbach; Bernard Krüger
Journal:  Sci Rep       Date:  2021-09-21       Impact factor: 4.379

3.  Effect of dexmedetomidine on postoperative delirium in patients undergoing brain tumour resections: study protocol of a randomised controlled trial.

Authors:  Dexiang Wang; Ruowen Li; Shu Li; Juan Wang; Min Zeng; Jia Dong; Xiaoyuan Liu; Nan Lin; Yuming Peng
Journal:  BMJ Open       Date:  2021-11-10       Impact factor: 2.692

4.  Current status of delirium assessment tools in the intensive care unit: a prospective multicenter observational survey.

Authors:  Kenzo Ishii; Kosuke Kuroda; Chika Tokura; Masaaki Michida; Kentaro Sugimoto; Tetsufumi Sato; Tomoki Ishikawa; Shingo Hagioka; Nobuki Manabe; Toshiaki Kurasako; Takashi Goto; Masakazu Kimura; Kazuharu Sunami; Kazuyoshi Inoue; Takashi Tsukiji; Takeshi Yasukawa; Satoshi Nogami; Mitsunori Tsukioki; Daisuke Okabe; Masaaki Tanino; Hiroshi Morimatsu
Journal:  Sci Rep       Date:  2022-02-09       Impact factor: 4.379

5.  Feasibility of low-dose dexmedetomidine for prevention of postoperative delirium after intracranial operations: a pilot randomized controlled trial.

Authors:  Xuan He; Kun-Ming Cheng; Yu-Qing Duan; Shan-Shan Xu; Hao-Ran Gao; Ming-Yue Miao; Hong-Liang Li; Kai Chen; Yan-Lin Yang; Linlin Zhang; Hong-Qiu Gu; Jian-Xin Zhou
Journal:  BMC Neurol       Date:  2021-12-04       Impact factor: 2.474

6.  Higher Grade Glioma Increases the Risk of Postoperative Delirium: Deficient Brain Compensation Might Be a Potential Mechanism of Postoperative Delirium.

Authors:  Hua-Wei Huang; Xiao-Kang Zhang; Hao-Yi Li; Yong-Gang Wang; Bin Jing; You Chen; Mayur B Patel; E Wesley Ely; Ya-Ou Liu; Jian-Xin Zhou; Song Lin; Guo-Bin Zhang
Journal:  Front Aging Neurosci       Date:  2022-04-13       Impact factor: 5.750

7.  Delirium-related factors and their prognostic value in patients undergoing craniotomy for brain metastasis.

Authors:  Jihwan Yoo; Bio Joo; Juyeong Park; Hun Ho Park; Mina Park; Sung Jun Ahn; Sang Hyun Suh; Jae-Jin Kim; Jooyoung Oh
Journal:  Front Neurol       Date:  2022-09-26       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.